SmallCap Sentinel: A Gain of Uncommon Proportions

ORLANDO, FL / ACCESSWIRE / March 13, 2019 / In the world of smaller equities, revenue, especially for emerging biotech or tech companies, can be fleeting, rare even. Most companies endeavor for years to execute a business plan and to deliver some positivity to the proforma. As such, Spherix Incorporated SPEX posting a one-time gain of $7.5 million in its 10-K should turn a few heads.

But there is a bigger picture and a line from the 10-k that is rarely seen for a stock trading presently under $1

'Spherex has total assets of $13.3 million, approximately 8 million shares currently outstanding and no debt.'

We thought the video of Spherex's own technology helping restore mobility to a mouse paralyzed by Acute Lymphoblastic Leukemia was head-turning but the preceding line from yesterday's 10-k may be its equal. (Do check out the mouse video)

It is notable that the $7.5 million one-time gain comes from an investment the Company and Spherex CEO Anthony Hayes made two years ago, putting $670k into a then private biotech called Hoth Therapeutics where Hayes saw potential and promise. The gain should give both capital and confidence to an opportunity agnostic company like Spherex that describes itself as "a technology development company committed to the fostering of innovative ideas."

Well, one down, and it was for $7.5 million.

No debt and $13.3 million in assets is a substantial runway for a company looking to incubate a slew of technologies in partnership with major universities like the University of Texas and Wake Forest for broad applications like pancreatic cancer or Acute Lymphoblastic Leukemia.

Meanwhile, they've also got a very large stake in a next-generation scooter company.

Admittedly, Spherex's diversity of interests is non-traditional. But in a marketplace of ideas it is often the avant-garde that leads the pack, the non-traditional which is the agent of change and the bold which claims the new. With a significant $7.5 gain now on its books Spherex can certainly point to an early success as an endorsement of this non-traditional model.

About Spherix Incorporated

Spherix Incorporated is a technology development company committed to the fostering of innovative ideas. Spherix Incorporated was formed in 1967 as a scientific research company. Our activities generally include the acquisition and development of technology through internal or external research and development. In addition, we seek to acquire existing rights to intellectual property through the acquisition of already issued patents and pending patent applications, both in the United States and abroad. We may alone, or in conjunction with others, develop products and processes associated with technology development and monetizing related intellectual property.

About SmallCap Sentinel:

SmallCap Sentinel is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience. Our network consists of stock brokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets.

For more informative reports such as this, please sign up at http://www.emergingmarketsllc.com/newsletter.php

Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below.

We may purchase Securities of the Profiled Company prior to their securities becoming publicly traded, which we may later sell publicly before, during or after our dissemination of the Information, and make profits therefrom. EMC does not verify or endorse any medical claims for any of its client companies.

EMC has been paid 55000 dollars for various marketing services including this report. EMC does not independently verify any of the content linked-to from this editorial. A contributor to this report (Integrity Media) receives $3,500 a month for a period of six months for investor relations and consulting services on the behalf of Spherix.

http://emergingmarketsllc.com/disclaimer.php

Emerging Markets Consulting, LLC

Florida Office
15701 State Road 50, Suite #205
Clermont, FL 34711
E-mail: jamespainter@emergingmarketsllc.com
Web: www.emergingmarketsllc.com

SOURCE: Emerging Markets Consulting, LLC